Whole-Exome Sequencing Reveals Clinical Potential of Circulating Tumor DNA from Peritoneal Fluid and Plasma in Endometrial Cancer

SIMPLE SUMMARY: Studies on biomarkers for endometrial cancer using circulating tumor DNA (ctDNA) from liquid biopsy samples are lacking. The aim of this study was to analyze gDNA from tumor tissues and ctDNA derived from peritoneal fluid and plasma samples and determine their mutational concordance...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Hye-Yeon, Ho, Jung Yoon, Kang, Jun, Hur, Soo Young, Kim, Sejin, Choi, Youn Jin, Han, Mi-Ryung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139435/
https://www.ncbi.nlm.nih.gov/pubmed/35626111
http://dx.doi.org/10.3390/cancers14102506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139435/
https://www.ncbi.nlm.nih.gov/pubmed/35626111
http://dx.doi.org/10.3390/cancers14102506

Ejemplares similares